Sequoia Financial Advisors, LLC Gilead Sciences, Inc. Transaction History

Sequoia Financial Advisors, LLC

$8.93 Billion
Q3 2024

A detailed history of Sequoia Financial Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 95,742 shares of GILD stock, worth $8.75 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

95,742

Previous 96,484 0.77%

Holding current value

$8.75 Million

Previous $6.62 Million 21.24%

% of portfolio

0.09%

Previous 0.08%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$66.59 - $83.99 $49,409 - $62,320	-742 Reduced 0.77%	95,742 $8.03 Million
Q2 2024 Jul 15, 2024	SELL	$63.15 - $72.88 $528,565 - $610,005	-8,370 Reduced 7.98%	96,484 $6.62 Million
Q1 2024 Apr 30, 2024	SELL	$71.58 - $87.29 $949,365 - $1.16 Million	-13,263 Reduced 11.23%	104,854 $7.68 Million
Q4 2023 Jan 25, 2024	BUY	$73.27 - $83.09 $753,581 - $854,580	10,285 Added 9.54%	118,117 $9.57 Million
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $368,295 - $401,817	-4,981 Reduced 4.42%	107,832 $8.08 Million
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $2.47 Million - $2.82 Million	-32,483 Reduced 22.36%	112,813 $8.69 Million
Q1 2023 Apr 24, 2023	BUY	$77.31 - $88.08 $567,378 - $646,419	7,339 Added 5.32%	145,296 $12.1 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $31,970 - $45,898	-513 Reduced 0.37%	137,957 $11.8 Million
Q4 2022 Jan 17, 2023	BUY	$62.32 - $89.47 $1.2 Million - $1.73 Million	19,310 Added 16.21%	138,470 $0
Q3 2022 Oct 26, 2022	BUY	$59.54 - $68.01 $807,898 - $922,827	13,569 Added 12.85%	119,160 $7.35 Million
Q2 2022 Jul 22, 2022	BUY	$57.72 - $65.01 $712,842 - $802,873	12,350 Added 13.25%	105,591 $6.53 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $849,396 - $1.06 Million	14,665 Added 18.66%	93,241 $5.54 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $4.15 Million - $4.7 Million	63,889 Added 435.0%	78,576 $5.71 Million
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $3.31 Million - $3.57 Million	-48,847 Reduced 76.88%	14,687 $1.03 Million
Q2 2021 Jul 27, 2021	BUY	$63.47 - $69.35 $914,221 - $998,917	14,404 Added 29.32%	63,534 $4.38 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $284,040 - $324,089	4,734 Added 10.66%	49,130 $3.18 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $485,547 - $553,258	8,571 Added 23.92%	44,396 $2.59 Million
Q3 2020 Oct 23, 2020	BUY	$62.1 - $78.08 $488,168 - $613,786	7,861 Added 28.11%	35,825 $2.26 Million
Q2 2020 Aug 25, 2020	BUY	$72.34 - $84.0 $2.02 Million - $2.35 Million	27,964 New	27,964 $2.15 Million
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $2.17 Million - $2.52 Million	-29,947 Closed	0 $2.15 Million
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $75,030 - $96,103	1,198 Added 4.17%	29,947 $2.24 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $208,706 - $229,570	-3,387 Reduced 10.54%	28,749 $1.87 Million
Q3 2019 Oct 22, 2019	BUY	$62.51 - $69.0 $4,188 - $4,623	67 Added 0.21%	32,136 $2.04 Million
Q2 2019 Jul 31, 2019	SELL	$61.87 - $69.38 $252,120 - $282,723	-4,075 Reduced 11.27%	32,069 $2.17 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $421,202 - $471,856	6,736 Added 22.91%	36,144 $2.35 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $3.8 Million - $4.96 Million	-62,791 Reduced 68.1%	29,408 $1.84 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $6,985 - $7,734	98 Added 0.11%	92,199 $7.12 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $56,445 - $65,841	870 Added 0.95%	92,101 $6.52 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $104,525 - $127,428	1,435 Added 1.6%	91,231 $6.88 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $166,348 - $195,269	2,338 Added 2.67%	89,796 $6.43 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $134,196 - $159,059	1,861 Added 2.17%	87,458 $7.09 Million
Q2 2017 Aug 09, 2017	BUY	N/A	85,597	85,597 $6.06 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.

Account

Sequoia Financial Advisors, LLC Gilead Sciences, Inc. Transaction History